As of Feb 16
| +0.0198 / +2.02%|
The 1 analysts offering 12-month price forecasts for Genocea Biosciences Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +400.00% increase from the last price of 1.00.
The current consensus among 2 polled investment analysts is to Buy stock in Genocea Biosciences Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.